Neurology Today in 5
Сувгийн дэлгэрэнгүй
Neurology Today in 5
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.
Сүүлийн дугаар
200 дугаар
50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment,...
Novel PET radiotracer, GLP-1s and dementia risk, green space benefits
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin en...
Pegivirus’ role in Parkinson’s disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about pegivirus's potential role in Parkinson's disease pathology, t...
Food deserts and stroke risk, physical activity in Parkinson’s disease, rimegepant for migraine
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, "food deserts," and stroke ri...
Parkinson’s and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson's disease from...
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Meri...
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, “Neurology in America”
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how po...
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growin...
Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-l...
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complic...
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complic...
Advances in cell therapies for Parkinson’s, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe an...
Microplastics in brain, salary gap in neurology, the neurology of space
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, th...
Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear.
In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vita...
New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neurom...
Impact of NIH cuts on neurology research, response to ACP’s guideline on migraine, an updated position on seizures, driver licensure, and medical reporting
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new...
Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled p...
IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.
In this week's podcast, Neurology Today's editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associa...
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of...
Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdur...
Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral p...
Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty
In this week's podcast, Neurology Today's editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest,...
3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration
In this week's podcast, Neurology Today's editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR...
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure t...
Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
In this week's podcast, Neurology Today's editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and...
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migra...
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
In this week's podcast, Neurology Today's editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand...
Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
In this week's podcast, Neurology Today's editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson's gene vari...
Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
In this week's podcast, Neurology Today's editor-in-chief highlights a new workgroup's recommendations on biomarkers for diagnosing Alzheimer's, AI's...
Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
In this week's podcast, Neurology Today's editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropa...
Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
In this week's podcast, Neurology Today's editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neu...
Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduc...
Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
In this week's podcast, Neurology Today's editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails...
When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
In this week's podcast, Neurology Today's editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data...
Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics
In this week's podcast, Neurology Today's editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracereb...
Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers
In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intrace...
Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative...
ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chr...
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assess...
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a Europe...